About VELOXIS PHARMACEUTICALS, INC.
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®. Veloxis is focused on building a clinical and market-stage pharmaceutical business around its late-stage transplant immunosuppression product candidate LCP-Tacro. The company was founded in 2002 as a spin-off from H. Lundbeck A/S. Veloxis is headquartered in Hørsholm, Denmark, with an office in Cary, North Carolina.
Source: Wikipedia
Headquarters2000 Regency Parkway, 27518, Cary, US
Founded2016
StatusActive
Patents5 patents
Stabilized tacrolimus compositionUS12403095B2 · 2025
STABILIZED TACROLIMUS COMPOSITIONUS2023101012A1 · 2023
Sign in to see all 5 patents
Browse the full patent portfolio, with publication numbers, dates and families.
Sign in Create an account with your emailIt's free
By continuing, you agree to Heelky's User Agreement, Privacy Policy and Cookie Policy.
Reviews
No reviews yet. Worked with VELOXIS PHARMACEUTICALS, INC.? Be the first to share your experience.
Legal information
| Legal name | VELOXIS PHARMACEUTICALS, INC. |
|---|---|
| LEI | 549300YD7MO7TUE8GX79View on GLEIF ↗ |
| Registered address | 2000 Regency Parkway, 27518, Cary, US |
| Status | Active |
Sources: GLEIF · updated Oct. 16, 2026
Contact & links
Location
2000 Regency Parkway, 27518, Cary, US
Is this your company?
Claim this page for free to add your logo, products, photos and jobs, and to answer reviews.
Claim this pageJoin Heelky to connect, hire and grow
Create a free account to message people, apply to jobs and post missions.
Join now — it's free